Search research articles
Contact Us
Filters
Showing results (221-230 of 277) with videos related to
Page
of 28
Sort By:
Molecules (Basel, Switzerland)
|
July 2, 2021
Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
Ziad Omran, Chris P Guise, Linwei Chen, et al.
Molecular Cancer
|
June 14, 2013
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
Laura K Green, Sophie P Syddall, Kendall M Carlin, et al.
Journal of Medicinal Chemistry
|
March 10, 2022
Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4
Min Shao, Xiaojuan Chen, Fang Yang, et al.
Plos One
|
June 14, 2018
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration
Makoto M Jones, Kevin L Winthrop, Scott D Nelson, et al.
Journal of Medicinal Chemistry
|
January 6, 2026
Design, Synthesis, and Biological Evaluation of the First Novel Macrocycle-Based FGFR Inhibitors That Overcome Clinically Acquired Resistance
Shuang Xiang, Xiaojuan Chen, Jieying Lin, et al.
Neurology and Therapy
|
March 9, 2019
Risperdal<sup>®</sup> CONSTA<sup>®</sup> Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
Marsha A Wilcox, Danielle Coppola, Nicole Bailey, et al.
Bioorganic Chemistry
|
April 19, 2025
Optimization of Aminoindazole derivatives as highly selective covalent inhibitors for wild-type and mutant FGFR4
Jing Guo, Xiaojuan Chen, Xiaofei Li, et al.
Medical Care
|
February 27, 2019
Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data
Ranier Bustamante, Ashley Earles, James D Murphy, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Adriana Estrada-Bernal, Anh T Le, Andrea E Doak, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 277) with videos related to
Sort By:
Page
of 28
Molecules (Basel, Switzerland)
|
July 2, 2021
Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
Ziad Omran, Chris P Guise, Linwei Chen, et al.
Molecular Cancer
|
June 14, 2013
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
Laura K Green, Sophie P Syddall, Kendall M Carlin, et al.
Journal of Medicinal Chemistry
|
March 10, 2022
Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4
Min Shao, Xiaojuan Chen, Fang Yang, et al.
Plos One
|
June 14, 2018
Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration
Makoto M Jones, Kevin L Winthrop, Scott D Nelson, et al.
Journal of Medicinal Chemistry
|
January 6, 2026
Design, Synthesis, and Biological Evaluation of the First Novel Macrocycle-Based FGFR Inhibitors That Overcome Clinically Acquired Resistance
Shuang Xiang, Xiaojuan Chen, Jieying Lin, et al.
Neurology and Therapy
|
March 9, 2019
Risperdal<sup>®</sup> CONSTA<sup>®</sup> Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
Marsha A Wilcox, Danielle Coppola, Nicole Bailey, et al.
Bioorganic Chemistry
|
April 19, 2025
Optimization of Aminoindazole derivatives as highly selective covalent inhibitors for wild-type and mutant FGFR4
Jing Guo, Xiaojuan Chen, Xiaofei Li, et al.
Medical Care
|
February 27, 2019
Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data
Ranier Bustamante, Ashley Earles, James D Murphy, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
Amir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Adriana Estrada-Bernal, Anh T Le, Andrea E Doak, et al.
Page
of 28